Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

A common cough medicine may slow cognitive decline in people with Parkinson’s disease dementia, a clinical trial has revealed ...

Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

Can exercise slow, or even reverse, brain damage from Parkinson’s disease? Plus, hope on the horizon for patients living with ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.